Phibro Animal Health Corporation (PAHC)
NASDAQ: PAHC · Real-Time Price · USD
44.33
+1.25 (2.90%)
Nov 25, 2025, 4:00 PM EST - Market closed
Phibro Animal Health Income Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2016 - 2020 |
| 1,400 | 1,296 | 1,018 | 977.89 | 942.26 | 833.35 | Upgrade | |
Revenue Growth (YoY) | 33.72% | 27.37% | 4.07% | 3.78% | 13.07% | 4.12% | Upgrade |
Cost of Revenue | 956.65 | 890.59 | 704.07 | 679.65 | 656.55 | 561.97 | Upgrade |
Gross Profit | 443.03 | 405.62 | 313.61 | 298.24 | 285.72 | 271.38 | Upgrade |
Selling, General & Admin | 279.71 | 269.68 | 247.09 | 223.35 | 183.53 | 193.82 | Upgrade |
Research & Development | - | - | - | - | 20.83 | - | Upgrade |
Amortization of Goodwill & Intangibles | 2.38 | 2.38 | 2.99 | 3.05 | 2.98 | 2.69 | Upgrade |
Operating Expenses | 282.09 | 272.06 | 250.07 | 226.39 | 207.34 | 196.51 | Upgrade |
Operating Income | 160.94 | 133.56 | 63.54 | 71.85 | 78.38 | 74.87 | Upgrade |
Interest Expense | -41 | -35.26 | -23.01 | -18.68 | -12.69 | -12.7 | Upgrade |
Interest & Investment Income | 1.98 | 2.62 | 4.47 | 3.36 | 0.82 | 0.84 | Upgrade |
Currency Exchange Gain (Loss) | -10.37 | -7.87 | -23.86 | -2.46 | 5.22 | 4.48 | Upgrade |
EBT Excluding Unusual Items | 111.55 | 93.05 | 21.14 | 54.07 | 71.72 | 67.49 | Upgrade |
Merger & Restructuring Charges | -23.58 | -25.98 | -6.93 | - | -0.6 | - | Upgrade |
Gain (Loss) on Sale of Investments | - | - | - | - | 1.2 | - | Upgrade |
Legal Settlements | - | - | -4.2 | - | - | - | Upgrade |
Other Unusual Items | - | -1.96 | - | - | - | -1.02 | Upgrade |
Pretax Income | 94.64 | 67.99 | 10.92 | 54.07 | 72.33 | 66.47 | Upgrade |
Income Tax Expense | 26.82 | 19.73 | 8.5 | 21.47 | 23.15 | 12.08 | Upgrade |
Net Income | 67.82 | 48.26 | 2.42 | 32.61 | 49.18 | 54.39 | Upgrade |
Net Income to Common | 67.82 | 48.26 | 2.42 | 32.61 | 49.18 | 54.39 | Upgrade |
Net Income Growth | 289.61% | 1897.68% | -92.59% | -33.69% | -9.58% | 62.09% | Upgrade |
Shares Outstanding (Basic) | 41 | 41 | 41 | 41 | 41 | 40 | Upgrade |
Shares Outstanding (Diluted) | 41 | 41 | 41 | 41 | 41 | 41 | Upgrade |
Shares Change (YoY) | 0.52% | 0.38% | 0.05% | - | - | - | Upgrade |
EPS (Basic) | 1.67 | 1.19 | 0.06 | 0.81 | 1.21 | 1.34 | Upgrade |
EPS (Diluted) | 1.67 | 1.19 | 0.06 | 0.81 | 1.21 | 1.34 | Upgrade |
EPS Growth | 288.74% | 1895.04% | -92.59% | -33.47% | -9.70% | 61.57% | Upgrade |
Free Cash Flow | 34.29 | 41.83 | 46.36 | -38.48 | -5.4 | 18.99 | Upgrade |
Free Cash Flow Per Share | 0.84 | 1.03 | 1.14 | -0.95 | -0.13 | 0.47 | Upgrade |
Dividend Per Share | 0.480 | 0.480 | 0.480 | 0.480 | 0.480 | 0.480 | Upgrade |
Gross Margin | 31.65% | 31.29% | 30.82% | 30.50% | 30.32% | 32.56% | Upgrade |
Operating Margin | 11.50% | 10.30% | 6.24% | 7.35% | 8.32% | 8.98% | Upgrade |
Profit Margin | 4.84% | 3.72% | 0.24% | 3.33% | 5.22% | 6.53% | Upgrade |
Free Cash Flow Margin | 2.45% | 3.23% | 4.55% | -3.94% | -0.57% | 2.28% | Upgrade |
EBITDA | 208.95 | 177.75 | 98.28 | 104.4 | 110.04 | 105.5 | Upgrade |
EBITDA Margin | 14.93% | 13.71% | 9.66% | 10.68% | 11.68% | 12.66% | Upgrade |
D&A For EBITDA | 48.01 | 44.18 | 34.74 | 32.56 | 31.66 | 30.63 | Upgrade |
EBIT | 160.94 | 133.56 | 63.54 | 71.85 | 78.38 | 74.87 | Upgrade |
EBIT Margin | 11.50% | 10.30% | 6.24% | 7.35% | 8.32% | 8.98% | Upgrade |
Effective Tax Rate | 28.34% | 29.02% | 77.87% | 39.70% | 32.01% | 18.18% | Upgrade |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.